Vinylogous acids
Search Within Results
1
–
2
of
2
results
1
![Medchemexpress LLC Quinazoline, 6,7-dimethoxy-4-[(3R)-3-(2-quinoxalinyloxy)-1-pyrrolidinyl]- | 927691-21-2 | 99.8% | 403.43 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000386990-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Quinazoline, 6,7-dimethoxy-4-[(3R)-3-(2-quinoxalinyloxy)-1-pyrrolidinyl]- | 927691-21-2 | 99.8% | 403.43 | 50 MG
PQ-10 is a potent inhibitor of Phosphodiesterase 10A (PDE10A) with IC50 and ED50 values of 4.6 nM and 13 mg/kg, respectively. It induces patterns of brain glucose metabolism, which can serve as a potential translational biomarker. It has the potential for researching psychiatric disorders like schizophrenia.
- Potent inhibitor of Phosphodiesterase 10A (PDE10A)
- IC50 of 4.6 nM
- ED50 of 13 mg/kg
- Induces patterns of brain glucose metabolism
- Potential translational biomarker
- Potential for researching psychiatric disorders like schizophrenia
2
Medchemexpress LLC FTISADTSK acetate | 99.7% | 1029.10 | 5 MG
FTISADTSK acetate is an endogenous stable signature peptide derived from Trastuzumab. It is specifically monitored by selected reaction monitoring (SRM) and is intended solely for research applications.
- Endogenous stable signature peptide
- Monitored by selected reaction monitoring (SRM)
- Suitable for research use only
- Solid appearance, ranging from white to light brown
- Molecular weight: 1029.10
- Chemical formula: C44H72N10O18
- Soluble in water at 50 mg/mL (48.59 mM), may require sonication
- Powder storage: -80°C for 2 years or -20°C for 1 year
- Solution storage: -80°C for 6 months or -20°C for 1 month (sealed, away from moisture)
- Ships at room temperature within the continental US